Renal outcome at 2 years in neonates with nephrocalcinosis and bronchopulmonary dysplasia: a case–control study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Two-Year Renal Outcomes in Neonates With Nephrocalcinosis and Bronchopulmonary Dysplasia: A Case–Control Study

  • By

  • Andrew Wade

  • Sumesh Thomas

  • Andrew Walker

  • Nahid Arjmand Kermani

  • Carlos Fajardo

  • October 15, 2026

Share

  • 1

    In this single-center retrospective study, 205 of 308 premature infants with bronchopulmonary dysplasia had nephrocalcinosis.

  • 2

    Furosemide exposure was more frequent with mild nephrocalcinosis than with no nephrocalcinosis (40.2% vs 24.3%; P = .007).

  • 3

    Gentamicin exposure was more frequent with mild or moderate/severe nephrocalcinosis than with no nephrocalcinosis.

  • 4

    UTIs occurred more often with moderate/severe than mild nephrocalcinosis (36.4% vs 11.2%; P = .004).

  • 5

    At age 2 years, nephrocalcinosis was not associated with haematuria or hypertension.

Original Source(s)

Related Content